The journal of nutrition, health & aging

, Volume 15, Issue 1, pp 25–31

HIgh dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the rancho bernardo study

  • L. B. Lopez
  • Donna Kritz-Silverstein
  • Elizabeth Barrett-Connor



This study examined the association of plasma DHA, dietary DHA, and fish intake with dementia and Alzheimer’s Disease (AD) in older adults.


Case-cohort study.


Clinic visit in 1991–93.


266 community dwelling men and women aged 67–100 years (mean=80.2).


Participants had neurological and neuropsychological evaluations for dementia in 1991–93. Plasma DHA was measured in blood samples obtained at that visit. Dietary intakes of DHA and fish were obtained from an earlier (1988–91) visit. Three DHA exposure variables were used in separate analyses; plasma DHA, dietary DHA, and consumption of cold-water fish. All-cause dementia included AD and other types of possible or probable dementia.


Among these 266 participants, 42 had dementia and 30 had possible or probable AD. Plasma DHA in the highest tertile was associated with a 65% reduced odds of allcause dementia (95% CI: 0.17, 0.92) and a 60% reduced odds of AD (95% CI: 0.15, 1.10). Dietary DHA in the highest tertile was associated with a 73% reduced odds of all-cause dementia (95% CI: 0.09, 0.79) and a 72% reduced odds of AD (95% CI: 0.09, 0.93). Fish intake had similar, though not significant, reduced odds of dementia (OR = 0.51; 95% CI: 0.20, 1.32) and AD (OR = 0.55; 95% CI: 0.20, 1.48).


Plasma and dietary DHA appear to protect against dementia. Increasing DHA intake from marine sources may be recommended for reducing dementia risk.

Key words

Alzheimer’s disease cognitive function dementia docosahexaenoic acid (DHA) omega-3 fatty acids 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    2008 Alzheimer’s disease facts and figures. Alzheimers Dement 2008;4:110–133.Google Scholar
  2. 2.
    Lanska DJ. Dementia mortality in the United States. Results of the 1986 National Mortality Followback Survey. Neurology 1998;50:362–367.PubMedGoogle Scholar
  3. 3.
    Lee JH, O’Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega3 fatty acids for cardioprotection. Mayo Clin Proc 2008;83:324–232.CrossRefPubMedGoogle Scholar
  4. 4.
    Bergmann C, Sano M. Cardiac risk factors and potential treatments in Alzheimer’s disease. Neurol Res 2006;28:595–604.CrossRefPubMedGoogle Scholar
  5. 5.
    Pomponi M, Pomponi M. DHA deficiency and Alzheimer’s disease. Clin Nutr 2008;27:170.CrossRefPubMedGoogle Scholar
  6. 6.
    Carriere I, Delcourt C, Lacroux A, Gerber M. Nutrient intake in an elderly population in southern France (POLANUT): deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res 2007;77:57–65.CrossRefPubMedGoogle Scholar
  7. 7.
    Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005;45:581–597.CrossRefPubMedGoogle Scholar
  8. 8.
    Brenna JT, Salem N, Jr., Sinclair AJ, Cunnane SC. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009;80:85–91.CrossRefPubMedGoogle Scholar
  9. 9.
    Biagi PL, Bordoni A, Hrelia S, Celadon M, Horrobin DF. Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta 6-desaturase activity. Biochim Biophys Acta 1991;1083:187–192.PubMedGoogle Scholar
  10. 10.
    Lopez Jimenez JA, Bordoni A, Lorenzini A, Rossi CA, Biagi PL, Hrelia S. Linoleic acid metabolism in primary cultures of adult rat cardiomyocytes is impaired by aging. Biochem Biophys Res Commun 1997;237:142–145.CrossRefPubMedGoogle Scholar
  11. 11.
    Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000;71:171S–175S.PubMedGoogle Scholar
  12. 12.
    Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res 1999;56:565–570.CrossRefPubMedGoogle Scholar
  13. 13.
    Das UN. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer’s disease-But how and why? Prostaglandins Leukot Essent Fatty Acids 2008;78:11–19.CrossRefPubMedGoogle Scholar
  14. 14.
    Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61:76–80.PubMedGoogle Scholar
  15. 15.
    Musiek ES, Brooks JD, Joo M, et al. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J Biol Chem 2008;283:19927–19935.CrossRefPubMedGoogle Scholar
  16. 16.
    Vedin I, Cederholm T, Freund Levi Y, et al. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am J Clin Nutr 2008;87:1616–1622.PubMedGoogle Scholar
  17. 17.
    Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;134:1806–1811.PubMedGoogle Scholar
  18. 18.
    Crawford MA. Docosahexaenoic acid in neural signaling systems. Nutr Health 2006;18:263–276.PubMedGoogle Scholar
  19. 19.
    Jump DB, Botolin D, Wang Y, Xu J, Demeure O, Christian B. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids 2008;153:3–13.CrossRefPubMedGoogle Scholar
  20. 20.
    Calon F, Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 2007;77:287–293.CrossRefPubMedGoogle Scholar
  21. 21.
    Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. Bmj 2002;325:932–933.CrossRefPubMedGoogle Scholar
  22. 22.
    Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003;60:940–946.CrossRefPubMedGoogle Scholar
  23. 23.
    Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006;63:1545–1550.CrossRefPubMedGoogle Scholar
  24. 24.
    Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology 2002;59:1915–1921.CrossRefPubMedGoogle Scholar
  25. 25.
    Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids 2000;35:1305–1312.CrossRefPubMedGoogle Scholar
  26. 26.
    Corrigan FM, Horrobin DF, Skinner ER, Besson JA, Cooper MB. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer’s disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol 1998;30:197–207.CrossRefPubMedGoogle Scholar
  27. 27.
    Wang W, Shinto L, Connor WE, Quinn JF. Nutritional biomarkers in Alzheimer’s disease: the association between carotenoids, n-3 fatty acids, and dementia severity. J Alzheimers Dis 2008;13:31–38.PubMedGoogle Scholar
  28. 28.
    Tully AM, Roche HM, Doyle R, et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease: a case-control study. Br J Nutr 2003;89:483–489.CrossRefPubMedGoogle Scholar
  29. 29.
    Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 2003;5:315–322.PubMedGoogle Scholar
  30. 30.
    Samieri C, Feart C, Letenneur L, et al. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 2008;88:714–721.PubMedGoogle Scholar
  31. 31.
    Cherubini A, Andres-Lacueva C, Martin A, et al. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007;62:1120–1126.PubMedGoogle Scholar
  32. 32.
    Criqui MH, Barrett-Connor E, Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 1978;108:367–372.PubMedGoogle Scholar
  33. 33.
    Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51–65.PubMedGoogle Scholar
  34. 34.
    Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.CrossRefPubMedGoogle Scholar
  35. 35.
    Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922–935.PubMedGoogle Scholar
  36. 36.
    Wiederholt WC, Cahn D, Butters NM, Salmon DP, Kritz-Silverstein D, Barrett-Connor E. Effects of age, gender and education on selected neuropsychological tests in an elderly community cohort. J Am Geriatr Soc 1993;41:639–647.PubMedGoogle Scholar
  37. 37.
    Reitan R. Validity of the Trail-Making Test as an indicator of organic brain disease. Percept Mot Skills 1958;8:271–276.CrossRefGoogle Scholar
  38. 38.
    Russell E. A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol 1975;43:800–809.CrossRefGoogle Scholar
  39. 39.
    Weschler D. A standardized memory scale for clinical use. J Psychol 1945;19:87–95.CrossRefGoogle Scholar
  40. 40.
    Borkowski J, Benton, AL, Spreen, O. Word fluency and brain damage. Neuropsychologia 1967;5:135–140.CrossRefGoogle Scholar
  41. 41.
    Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019–1025.PubMedGoogle Scholar
  42. 42.
    Frank R, Wiederholt WC, Kritz-Silverstein D, Salmon DP, Barrett-Connor E. Effects of sequential neuropsychological testing of an elderly community-based sample. Neruoepidemiology 1996;15:257–268.CrossRefGoogle Scholar
  43. 43.
    The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med 1976;5:207–215.Google Scholar
  44. 44.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.PubMedGoogle Scholar
  45. 45.
    Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497–509.PubMedGoogle Scholar
  46. 46.
    Arterburn LM, Oken HA, Hoffman JP, et al. Bioequivalence of Docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food. Lipids 2007;42:1011–1024.CrossRefPubMedGoogle Scholar
  47. 47.
    Zeleniuch-Jacquotte A, Chajès V, Van Kappel AL, Riboli E,, Toniolo P. Reliability of fatty acid composition in human serum phospholipids. Eur J Clin Nutr 2000;54:367–372.CrossRefPubMedGoogle Scholar
  48. 48.
    Hunter DJ, Rimm EB, Sacks FM, et al. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a freeliving population of US men. Am J Epidemiol 1992;135:418–427.PubMedGoogle Scholar
  49. 49.
    Garland M, Sacks FM, Colditz GA, et al. The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr 1998;67:25–30.PubMedGoogle Scholar
  50. 50.
    Siest G, Pillot T, Regis-Bailly A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995;41:1068–1086.PubMedGoogle Scholar
  51. 51.
    Soderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease. Lipids 1991;26:421–425.CrossRefPubMedGoogle Scholar
  52. 52.
    Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997;42:776–782.CrossRefPubMedGoogle Scholar
  53. 53.
    Huang TL, Zandi PP, Tucker KL, et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 2005;65:1409–1414.CrossRefPubMedGoogle Scholar
  54. 54.
    Welch AA, Bingham SA, Ive J, et al. Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer-Norfolk United Kingdom cohort. Am J Clin Nutr 2006;84:1330–1339.PubMedGoogle Scholar
  55. 55.
    Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009;139:804S–819S.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer Verlag France 2011

Authors and Affiliations

  • L. B. Lopez
    • 1
    • 2
  • Donna Kritz-Silverstein
    • 1
    • 3
  • Elizabeth Barrett-Connor
    • 1
  1. 1.Department of Family and Preventive MedicineUniversity of CaliforniaSan Diego, La JollaUSA
  2. 2.Department of Health and Behavior Studies, Teachers CollegeColumbia UniversityNew YorkUSA
  3. 3.Department of Family and Preventive MedicineUniversity of California San DiegoLa JollaUSA
  4. 4.Department of Family and Preventive MedicineUniversity of California, San DiegoLa JollaUSA

Personalised recommendations